{"entity":{"type":"insider","cik":"0001773187","url":"/insider/0001773187","json_url":"/insider/0001773187.json","name":"Bain Capital Life Sciences Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2021-12-10","last":"2025-02-21","span_basis":"filed_date"},"name_variants":[{"name":"Bain Capital Life Sciences Fund II, L.P.","source":"filing","n_filings":2,"first_seen":"2021-12-10","last_seen":"2025-02-21"}],"transactions":[{"id":4376092,"accession":"0000950170-25-025011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025011","line_url":"/filing/0000950170-25-025011#line-1","is_derivative":false,"issuer_cik":"0001702921","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001702921","owner_cik":null,"owner_name":"BCIP Life Sciences Associates, LP; BCLS II Equity Opportunities GP, LLC; BCLS II Equity Opportunities, LP; BCLS II Investco (GP), LLC; BCLS II Investco, LP; BCLS SB Investco, LP; Bain Capital Life Sciences Fund II, L.P.; Bain Capital Life Sciences Investors II, LLC; Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences Partners, LP","owner_display_name":"BCIP Life Sciences Associates, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":4030000.0,"total_display":"4,030,000.00","total_whole":"4,030,000","shares_owned_after":5034582.0,"shares_owned_after_display":"5,034,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":5133830,"accession":"0000899243-21-047829","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-047829","line_url":"/filing/0000899243-21-047829","is_derivative":false,"issuer_cik":"0001702921","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001702921","owner_cik":null,"owner_name":"BCIP Life Sciences Associates, LP; BCLS II Investco, LP; Bain Capital Life Sciences Fund II, L.P.; Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences Investors II, LLC; BCLS II Investo (GP), LLC","owner_display_name":"BCIP Life Sciences Associates, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":9.648090768,"price_display":"9.65","price_state":"stated","total_value":241202.2692,"total_display":"241,202.27","total_whole":"241,202","shares_owned_after":2802225.0,"shares_owned_after_display":"2,802,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider","n_lines":2},{"id":5133819,"accession":"0000899243-21-047829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-047829","line_url":"/filing/0000899243-21-047829#line-2","is_derivative":false,"issuer_cik":"0001702921","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001702921","owner_cik":null,"owner_name":"BCIP Life Sciences Associates, LP; BCLS II Investco, LP; Bain Capital Life Sciences Fund II, L.P.; Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences Investors II, LLC; BCLS II Investo (GP), LLC","owner_display_name":"BCIP Life Sciences Associates, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4011.0,"shares_display":"4,011","price_per_share":9.8442,"price_display":"9.84","price_state":"stated","total_value":39485.0862,"total_display":"39,485.09","total_whole":"39,485","shares_owned_after":2780413.0,"shares_owned_after_display":"2,780,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider"},{"id":5133813,"accession":"0000899243-21-047829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-047829","line_url":"/filing/0000899243-21-047829#line-1","is_derivative":false,"issuer_cik":"0001702921","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001702921","owner_cik":null,"owner_name":"BCIP Life Sciences Associates, LP; BCLS II Investco, LP; Bain Capital Life Sciences Fund II, L.P.; Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences Investors II, LLC; BCLS II Investo (GP), LLC","owner_display_name":"BCIP Life Sciences Associates, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13458.0,"shares_display":"13,458","price_per_share":9.6206,"price_display":"9.62","price_state":"stated","total_value":129474.0348,"total_display":"129,474.03","total_whole":"129,474","shares_owned_after":2776402.0,"shares_owned_after_display":"2,776,402","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001707502","name":"Solid Biosciences Inc.","url":"/issuer/0001707502","role":"Ten percent owner","n_filings":1,"first_seen":"2025-02-21","last_seen":"2025-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001840233","name":"Xilio Therapeutics, Inc.","url":"/issuer/0001840233","role":"Ten percent owner","n_filings":1,"first_seen":"2021-12-10","last_seen":"2021-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001773187","retrieved_at":"2026-08-22T13:35:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}